Secondary Bacterial Infection and Empirical Antibiotic Use in Toxic Epidermal Necrolysis Patients

The objective of this study was to determine rates of positive bacterial cultures in patients with extensive toxic epidermal necrolysis, the rate of bacteremia, whether empirical antibiotics had been commenced, and their effectiveness when commenced. The authors conducted a retrospective chart review of patients with extensive toxic epidermal necrolysis between January 2001 and December 2012 admitted to the Victorian Adult Burns Service, Melbourne, Australia, with respect to the amount of positive cultures, number and type of organisms identified, whether empirical antibiotics had been commenced, and whether antibiotics were effective against organisms cultured. A total of 27 patients were admitted over the study period of 11 years. Seventeen of these patients developed at least one positive bacterial culture. Patients who grew positive cultures had a longer length of stay in intensive care unit and in hospital overall compared with patients who did not grow positive cultures. Thirty-five positive cultures were collected overall, with empirical antibiotics commenced in 22 cases. In terms of sensitivity, antibiotics were appropriate in 19 cases. Four patients developed bacteremia, two of whom died. This study does not dispute the generally accepted practice of avoiding prophylactic antibiotics in toxic epidermal necrolysis patients, but in the context of a relatively low rate of bacteremia in this patient population, advises appropriate and targeted empirical antibiotic use where clinical infection is suspected.

[1]  R. Zajíček,et al.  Toxic epidermal necrolysis and Stevens‐Johnson syndrome at the Prague Burn Centre 1998–2008 , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  N. Moiemen,et al.  Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre , 2010, Clinical and experimental dermatology.

[3]  P. Mahar,et al.  Pseudomonas aeruginosa bacteraemia in burns patients: Risk factors and outcomes. , 2010, Burns : journal of the International Society for Burn Injuries.

[4]  J. Treat Stevens-Johnson syndrome and toxic epidermal necrolysis. , 2010, Pediatric annals.

[5]  L. Brochard,et al.  Bacteremia in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Epidemiology, Risk Factors, and Predictive Value of Skin Cultures , 2010, Medicine.

[6]  D. Hospenthal,et al.  Outcomes of bacteremia in burn patients involved in combat operations overseas. , 2008, Journal of the American College of Surgeons.

[7]  R. Kreis,et al.  Toxic epidermal necrolysis; 15 years’ experience in a Dutch burns centre , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  G. Gravante,et al.  More than two different bacterial species isolated from blood of toxic epidermal necrolysis patients significantly increase mortality. , 2006, Burns : journal of the International Society for Burn Injuries.

[9]  B. R. Sharma,et al.  Septicemia as a cause of death in burns: an autopsy study. , 2006, Burns : journal of the International Society for Burn Injuries.

[10]  B. Atiyeh,et al.  Treatment of Toxic Epidermal Necrolysis With Moisture‐Retentive Ointment: A Case Report and Review of the Literature , 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[11]  W. Rising,et al.  Outcome of Patients with Toxic Epidermal Necrolysis Syndrome Revisited , 2002, Plastic and reconstructive surgery.

[12]  C. Oster,et al.  A case report and a proposed algorithm for the transfer of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis to a burn center. , 2002, Military medicine.

[13]  A. Karagianni,et al.  Plasma exchange in patients with toxic epidermal necrolysis. , 2002, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

[14]  S. Ying,et al.  Toxic epidermal necrolysis: 10 years experience of a burns centre in Hong Kong. , 2001, Burns : journal of the International Society for Burn Injuries.

[15]  R. Sheridan,et al.  A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. , 2001, The Journal of burn care & rehabilitation.

[16]  J. Roujeau,et al.  Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? , 2000, Archives of dermatology.

[17]  R. Stern,et al.  Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. , 1996, The New England journal of medicine.

[18]  J. Roujeau The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. , 1994, The Journal of investigative dermatology.

[19]  J. Roujeau,et al.  Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. , 1987, Archives of dermatology.

[20]  L. Naldi,et al.  Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. , 2008, The Journal of investigative dermatology.

[21]  J. Hansbrough,et al.  A 10-year experience with toxic epidermal necrolysis. , 2001, The Journal of burn care & rehabilitation.